168 related articles for article (PubMed ID: 37535198)
21. The resolvin D1 levels before and after periodontal therapy in periodontitis patients.
Gokmenoglu C; Turkmen E; Öngöz Dede F; Erbak Yilmaz H; Kara MC; Çanakçi V
Clin Oral Investig; 2022 Oct; 26(10):6379-6385. PubMed ID: 35760881
[TBL] [Abstract][Full Text] [Related]
22. Beta-glucuronidase activity in saliva: relationship to clinical periodontal parameters.
Lamster IB; Kaufman E; Grbic JT; Winston LJ; Singer RE
J Periodontol; 2003 Mar; 74(3):353-9. PubMed ID: 12710755
[TBL] [Abstract][Full Text] [Related]
23. RvE1 Impacts the Gingival Inflammatory Infiltrate by Inhibiting the T Cell Response in Experimental Periodontitis.
Alvarez C; Abdalla H; Sulliman S; Rojas P; Wu YC; Almarhoumi R; Huang RY; Galindo M; Vernal R; Kantarci A
Front Immunol; 2021; 12():664756. PubMed ID: 34012448
[TBL] [Abstract][Full Text] [Related]
24. Nonsurgical periodontal therapy.
Drisko CH
Periodontol 2000; 2001; 25():77-88. PubMed ID: 11155183
[TBL] [Abstract][Full Text] [Related]
25. Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease.
Kantarci A; Aytan N; Palaska I; Stephens D; Crabtree L; Benincasa C; Jenkins BG; Carreras I; Dedeoglu A
Exp Neurol; 2018 Feb; 300():111-120. PubMed ID: 29126887
[TBL] [Abstract][Full Text] [Related]
26. Periodontal status affects C-reactive protein and lipids in patients with stable heart disease from a tertiary care cardiovascular clinic.
Flores MF; Montenegro MM; Furtado MV; Polanczyk CA; Rösing CK; Haas AN
J Periodontol; 2014 Apr; 85(4):545-53. PubMed ID: 23805809
[TBL] [Abstract][Full Text] [Related]
27. Gingival crevicular fluid interleukin-8 and lipoxin A4 levels of smokers and nonsmokers with different periodontal status: a cross-sectional study.
Lütfioğlu M; Aydoğdu A; Sakallioğlu EE; Alaçam H; Pamuk F
J Periodontal Res; 2016 Aug; 51(4):471-80. PubMed ID: 26446985
[TBL] [Abstract][Full Text] [Related]
28. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
29. Imbalanced serum levels of resolvin E1 (RvE1) and leukotriene B4 (LTB4) in patients with allergic rhinitis.
Lotfi R; Davoodi A; Mortazavi SH; Gorgin Karaji A; Tarokhian H; Rezaiemanesh A; Salari F
Mol Biol Rep; 2020 Oct; 47(10):7745-7754. PubMed ID: 32960415
[TBL] [Abstract][Full Text] [Related]
30. Effect of phase I periodontal therapy on pro-coagulant state in chronic periodontitis patients--a clinical and haematological study.
Banthia R; Jain P; Banthia P; Belludi S; Parwani S; Jain A
J Ir Dent Assoc; 2013; 59(4):183-8. PubMed ID: 24156210
[TBL] [Abstract][Full Text] [Related]
31. Lipid emulsion rich in n-3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cells.
Noureddine N; Hartling I; Wawrzyniak P; Srikanthan P; Lou PH; Lucchinetti E; Krämer SD; Rogler G; Zaugg M; Hersberger M
Am J Clin Nutr; 2022 Sep; 116(3):786-797. PubMed ID: 35849016
[TBL] [Abstract][Full Text] [Related]
32. [Effect of periodontal initial therapy on the serum level of lipid in the patients with both periodontitis and hyperlipidemia].
Duan JY; Ou-Yang XY; Zhou YX
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Feb; 41(1):36-9. PubMed ID: 19221561
[TBL] [Abstract][Full Text] [Related]
33. Prevention and treatment of periodontal diseases in primary care.
Matthews DC
Evid Based Dent; 2014 Sep; 15(3):68-9. PubMed ID: 25343386
[TBL] [Abstract][Full Text] [Related]
34. Impact of Resolvin D1 on the inflammatory phenotype of periodontal ligament cell response to hypoxia.
Cai J; Liu J; Yan J; Lu X; Wang X; Li S; Mustafa K; Wang H; Xue Y; Mustafa M; Kantarci A; Xing Z
J Periodontal Res; 2022 Oct; 57(5):1034-1042. PubMed ID: 35944267
[TBL] [Abstract][Full Text] [Related]
35. Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin.
Salic K; Morrison MC; Verschuren L; Wielinga PY; Wu L; Kleemann R; Gjorstrup P; Kooistra T
Atherosclerosis; 2016 Jul; 250():158-65. PubMed ID: 27236706
[TBL] [Abstract][Full Text] [Related]
36. Effect of periodontal treatment on lipoproteins levels in plasma in patients with periodontitis.
Pejcic A; Kesic L; Brkic Z; Pesic Z; Mirkovic D
South Med J; 2011 Aug; 104(8):547-52. PubMed ID: 21886061
[TBL] [Abstract][Full Text] [Related]
37. Periodontal status in subjects with hyperlipidemia.
Fentoğlu O; Oz G; Taşdelen P; Uskun E; Aykaç Y; Bozkurt FY
J Periodontol; 2009 Feb; 80(2):267-73. PubMed ID: 19186967
[TBL] [Abstract][Full Text] [Related]
38. Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling.
Markworth JF; Brown LA; Lim E; Castor-Macias JA; Larouche J; Macpherson PCD; Davis C; Aguilar CA; Maddipati KR; Brooks SV
Aging Cell; 2021 Jun; 20(6):e13393. PubMed ID: 34075679
[TBL] [Abstract][Full Text] [Related]
39. Serum plasminogen activator inhibitor-1 and tumor necrosis factor-α levels in obesity and periodontal disease.
Akman PT; Fentoğlu O; Yılmaz G; Arpak N
J Periodontol; 2012 Aug; 83(8):1057-62. PubMed ID: 22141357
[TBL] [Abstract][Full Text] [Related]
40. Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis.
Özgül Özdemir RB; Soysal Gündüz Ö; Özdemir AT; Akgül Ö
Immunol Lett; 2020 Nov; 227():34-40. PubMed ID: 32818598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
